ID   K9TCC#4Molly
AC   CVCL_1R37
DR   Wikidata; Q54899449
RX   PubMed=24964787;
RX   PubMed=29732388;
CC   Doubling time: 44.69 hours (PubMed=24964787).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 10
//
RX   PubMed=24964787; DOI=10.1186/1471-2407-14-465; PMCID=PMC4082678;
RA   Rathore, Kusum
RA   Cekanova, Maria
RT   "Animal model of naturally occurring bladder cancer: characterization
RT   of four new canine transitional cell carcinoma cell lines.";
RL   BMC Cancer 14:465.1-465.10(2014).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350;
RA   Zuiverloon, Tahlita C.M.
RA   de Jong, Florus Christiaan
RA   Costello, James C.
RA   Theodorescu, Dan
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//